U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
134641134641Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver TransplantationWithdrawnNo Results AvailableChronic Hepatitis B Liver Disease|Orthostotic Liver TransplantBiological: Hepatitis B immune globulin (Human)https://ClinicalTrials.gov/show/NCT00800787
134642134642Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years OldCompletedNo Results AvailableAnisometropiaProcedure: LASIKhttps://ClinicalTrials.gov/show/NCT00800774
134643134643Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia MajorCompletedNo Results AvailableIron Overload|CardiomyopathyDrug: Deferoxamine and Deferiprone|Drug: Deferoxaminehttps://ClinicalTrials.gov/show/NCT00800761
134644134644A Study of Combination Treatment With PEGASYS (Peginterferon Alfa-2a (40KD) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C.CompletedNo Results AvailableHepatitis C, ChronicDrug: peginterferon alfa-2a [Pegasys]|Drug: peginterferon alfa-2a [Pegasys]|Drug: ribavirin [Copegus]|Drug: ribavirin [Copegus]https://ClinicalTrials.gov/show/NCT00800748
134645134645A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner ProtocolsCompletedHas ResultsHepatitis C, ChronicDrug: Pegylated-interferon alfa-2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00800735
134646134646A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.CompletedNo Results AvailablePort Wine StainDrug: Rapamycin Treatment of Port Wine Stainhttps://ClinicalTrials.gov/show/NCT00800722
134647134647Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer's DiseaseDrug: Memantinehttps://ClinicalTrials.gov/show/NCT00800709
134648134648Preventive Oral CareActive, not recruitingNo Results AvailableFever|Respiratory InfectionProcedure: oral carehttps://ClinicalTrials.gov/show/NCT00800696
134649134649Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background InclusiveCompletedHas ResultsDiabetes Mellitus, Type 2Drug: BI 1356|Drug: placebohttps://ClinicalTrials.gov/show/NCT00800683
134650134650Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis VaccineTerminatedNo Results AvailableTuberculosisBiological: Ad5Ag85A|Biological: Ad5Ag85Ahttps://ClinicalTrials.gov/show/NCT00800670
134651134651Stem Cells and Resynchronization CardiacRecruitingNo Results AvailableHeart FailureProcedure: Pacing and Stem Cells Implantations.|Procedure: Pacing and Stem Cells Implantationhttps://ClinicalTrials.gov/show/NCT00800657
134652134652Pelvic Fractures and Radiation Therapy for Cervical CancerRecruitingNo Results AvailableCervical Cancer|Endometrial Cancer|Vaginal CancerProcedure: CT or MRI + Blood Testhttps://ClinicalTrials.gov/show/NCT00800644
134653134653The Biomarker and Cardiac Function in SepsisRecruitingNo Results AvailableSepsishttps://ClinicalTrials.gov/show/NCT00800631
134654134654A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young WomenCompletedNo Results AvailableEndometriosisDrug: PF-02413873 100 mg QD|Drug: PF-02413873 1500 mg QD|Drug: PF-02413873 20 mg QD|Drug: PF-02413873 500 mg QD|Drug: PF-02413873 Placebohttps://ClinicalTrials.gov/show/NCT00800618
134655134655Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza InfectionCompletedNo Results AvailableInfluenzaBiological: Vero cell-derived, trivalent, seasonal influenza vaccine|Biological: Placebo: Phosphate-buffered salinehttps://ClinicalTrials.gov/show/NCT00800605
134656134656Sildenafil IV Bolus StudyCompletedNo Results AvailableHypertension, Pulmonary [C08.381.423]Drug: sildenafilhttps://ClinicalTrials.gov/show/NCT00800592
134657134657Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male VolunteersCompletedNo Results AvailableCystic FibrosisDrug: GS-9411|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00800579
134658134658Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL)WithdrawnNo Results AvailableLeukemia|Chronic Lymphocytic LeukemiaDrug: Oral Clofarabinehttps://ClinicalTrials.gov/show/NCT00800566
134659134659fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived AdultsCompletedNo Results AvailableSleep DeprivationDrug: donepezilhttps://ClinicalTrials.gov/show/NCT00800553
134660134660Circadian Ocular Perfusion Pressure and Ocular Blood FlowCompletedHas ResultsGlaucomaDrug: Brinzolamide 10 mg/ml/Timolol 5 mg/ml eye drops suspension|Drug: Brimonidine 20 mg/ml/Timolol 5 mg/ml eye drops solutionhttps://ClinicalTrials.gov/show/NCT00800540
134661134661Efficacy of Gabapentin in the Treatment of Chest Pain and Paresthesia in Patients With SternotomyCompletedNo Results AvailableChest Pain|ParesthesiaDrug: Gabapentin|Drug: Diclofenachttps://ClinicalTrials.gov/show/NCT00800527
134662134662Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)TerminatedNo Results AvailableTraumatic Brain InjuryDrug: amantadine|Drug: amantadinehttps://ClinicalTrials.gov/show/NCT00800514
134663134663A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral SclerosisCompletedNo Results AvailableAmyotrophic Lateral SclerosisDrug: sNN0029|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00800501
134664134664Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 MonthsCompletedNo Results AvailableFever|Bacterial Infectionhttps://ClinicalTrials.gov/show/NCT00800488
134665134665Bioequivalence Study Between Two Oral Formulations of Gemfibrozil TabletsCompletedNo Results AvailableBioavailabilityDrug: Gemfibrozil Tabletshttps://ClinicalTrials.gov/show/NCT00800475
134666134666Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor OveractivityCompletedNo Results AvailableSpinal Cord Injury|Neurogenic Detrusor OveractivityDrug: Oxybutynin Cl|Drug: Trospium Cl|Drug: Darifenacin Hydrogen Bromide (HBr)https://ClinicalTrials.gov/show/NCT00800462
134667134667Distribution of Haptoglobin Phenotype in Septic and Non Septic Pre-term Neonates (PTSH)CompletedNo Results AvailableNeonatal Sepsishttps://ClinicalTrials.gov/show/NCT00800449
134668134668A Dose Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and HER2 Positive Female PatientsCompletedNo Results AvailableBreast CancerDrug: trastuzumab [Herceptin]|Drug: trastuzumab [Herceptin]|Drug: trastuzumab [Herceptin]|Drug: trastuzumab [Herceptin]|Drug: trastuzumab [Herceptin]https://ClinicalTrials.gov/show/NCT00800436
134669134669Effect of Topical Brimonidine on Post Cataract Surgery Corneal EdemaNot yet recruitingNo Results AvailableCorneal Edema|Visual AcuityDrug: Brimonidine Tartrate 0.2%|Drug: Timolol maleate 0.5%https://ClinicalTrials.gov/show/NCT00800423
134670134670REACH Detroit Partnership Family InterventionCompletedNo Results AvailableDiabetes MellitusBehavioral: Community Health Worker (CHW) serviceshttps://ClinicalTrials.gov/show/NCT00800410

* Görseller ve İçerik tekif hakkına sahip olabilir